1611042984.030758918s af127fe5-ce83-493f-83d2-8b630e6020a3:V +qQzEakEYVDYlpAxZ7ewyPPOoHzmdcdVg#ds003477/derivatives/fmriprep/sub-03/figures/sub-03_ses-1_task-face_run-2_desc-validation_bold.html
1611042986.643268722s af127fe5-ce83-493f-83d2-8b630e6020a3:V +FZwOSq8B36NPhwfo5xUPzWNqZuI220XG#ds003477/derivatives/fmriprep/sub-03/figures/sub-03_ses-1_task-face_run-3_desc-validation_bold.html
1611042989.447974649s af127fe5-ce83-493f-83d2-8b630e6020a3:V +QBQIR_vN3UUdLcAq7JzkHbiKhykjMZDL#ds003477/derivatives/fmriprep/sub-03/figures/sub-03_ses-1_task-face_run-4_desc-validation_bold.html
1611042991.931557873s af127fe5-ce83-493f-83d2-8b630e6020a3:V +cBGTBBmCf6MdWG7.Kutm.CRYlCHaXqwZ#ds003477/derivatives/fmriprep/sub-03/figures/sub-03_ses-1_task-face_run-5_desc-validation_bold.html
1611042994.574440456s af127fe5-ce83-493f-83d2-8b630e6020a3:V +_0mvRDciyCG4oFqn9Akc1yUTISKXJ5NH#ds003477/derivatives/fmriprep/sub-03/figures/sub-03_ses-1_task-face_run-6_desc-validation_bold.html
1611042997.115127913s af127fe5-ce83-493f-83d2-8b630e6020a3:V +b1xuibs6MGv0B.6DuLCZdnuphvYozATr#ds003477/derivatives/fmriprep/sub-03/figures/sub-03_ses-1_task-flocBLOCKED_desc-validation_bold.html
